Philippines Adds Australia's CSL As Potential Vaccine Source

The Oxford University Vaccine is now being trailed and if all goes to plan, the government said it will get 84 million doses, with 3.8 million rolled out as early as January.

The company also said it had agreed with the Australian government to manufacture an alternative potential vaccine it is developing with the University of Queensland (UQ), with first doses of that vaccine expected by mid-2021. A Sinovac representative told AFP his firm has already "completed the construction of a vaccine factory" able to produce 300 million doses a year.

It will take possession of the first 3.8 million doses of the AstraZeneca vaccine in January and February 2021, and then receive a further 30 million doses, Morrison will say in extracts from an announcement sent to Reuters.

Australia said in August it had signed a preliminary agreement with AstraZeneca for enough doses for its population of almost 26 million, which would be manufactured locally by pharmaceutical company CSL.

China National Biotec Group (CNBG) and Sinovac Biotech Ltd said on Saturday they have each found two more countries to run late-stage clinical tests of their coronavirus vaccine candidates, as China steps up its efforts in the global race.

Britain's Got Talent returns with semi-final after pandemic hiatus
Instead, a virtual audience will watch from their homes and their reactions will be broadcast into the studio on a giant screen. Amanda Holden, who will fill in as head judge in Cowell's absence, will have the deciding vote if there is a tie.

China has put its homegrown coronavirus vaccines on display for the first time, as the country where the contagion was discovered looks to shape the narrative surrounding the pandemic.

The Philippines, which has the most coronavirus infections and second largest number of COVID-19 deaths in Southeast Asia, has a population of 107 million people, making it a potentially large market for vaccine suppliers.

Under the deal with UQ and CSL, Australia will buy 51 million doses of that tie-up's vaccine.

J&J's vaccine is one of over a hundred worldwide being developed in response to the coronavirus pandemic, which has infected almost 26.5 million people and led to some 869,323 deaths. The potential vaccine is now in the Phase 1 stage of clinical trials.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.